Back to top
more

Henry Schein (HSIC)

(Delayed Data from NSDQ)

$70.37 USD

70.37
1,742,354

+0.14 (0.20%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $70.37 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (101 out of 250)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Indrajit Bandyopadhyay headshot

4 Stocks to Buy Amid Dental Supplies Industry Challenges

Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These include MCK, WST, ALGN and HSIC.

What's in Store for Patterson Companies (PDCO) in Q4 Earnings?

Patterson Companies' (PDCO) fiscal fourth-quarter results are likely to reflect an improvement in both the Dental and Animal Health segments.

Here's Why Henry Schein (HSIC) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Henry Schein (HSIC) Down 4.3% Since Last Earnings Report: Can It Rebound?

Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Henry Schein (HSIC) Banks on Global Expansion Amid Macro Issues

Within the Dental business, Henry Schein (HSIC) is aiming to deliver customized solutions, leveraging market insights and technological advancements.

Here's Why Henry Schein (HSIC) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Why Henry Schein (HSIC) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's Why You Should Retain Henry Schein (HSIC) Stock for Now

Investors are optimistic about Henry Schein (HSIC), owing to strategic acquisitions and potential in Henry Schein One.

Henry Schein (HSIC) Extends Partnership With Special Olympics

Henry Schein's (HSIC) extended collaboration with Special Olympics is likely to promote wellness and health education for athletes with ID around the world.

Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's What Key Metrics Tell Us About Henry Schein (HSIC) Q1 Earnings

While the top- and bottom-line numbers for Henry Schein (HSIC) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Henry Schein (HSIC) Tops Q1 Earnings, Lowers '24 Sales View

Henry Schein's (HSIC) first-quarter performance reflects a strong recovery from last year's cyber incident.

Henry Schein (HSIC) Surpasses Q1 Earnings Estimates

Henry Schein (HSIC) delivered earnings and revenue surprises of 11.11% and 1.76%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Henry Schein (HSIC) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Henry Schein (HSIC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.

West Pharmaceutical Services (WST) Tops Q1 Earnings and Revenue Estimates

West Pharmaceutical (WST) delivered earnings and revenue surprises of 20.93% and 3.27%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Align Technology (ALGN) Surpasses Q1 Earnings and Revenue Estimates

Align Technology (ALGN) delivered earnings and revenue surprises of 8.08% and 2.62%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Henry Schein (HSIC) Gears Up for Q1 Earnings: Factors to Note

Henry Schein's (HSIC) first-quarter 2024 results are likely to indicate a strong sales recovery post last year's cybersecurity incident.

Henry Schein (HSIC) Global Presence Aids, Macroeconomic Woes Stay

Henry Schein (HSIC) is busy promoting digital workflows for general dentistry and dental specialties.

Here's Why You Should Retain Henry Schein (HSIC) Stock for Now

Favorable Dental business trends and expansion efforts through acquisitions and partnerships bode well for Henry Schein (HSIC).

Henry Schein (HSIC) Buys TriMed to Expand in Orthopedic Space

According to Henry Schein (HSIC), the upper and lower extremities are among the fastest-growing segments of orthopedics, representing a total addressable market of more than $5.5 billion.

Why Is Henry Schein (HSIC) Down 1.8% Since Last Earnings Report?

Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Compared to Estimates, Henry Schein (HSIC) Q4 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Henry Schein (HSIC) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Henry Schein (HSIC) Q4 Earnings Miss, Operating Margin Down

Henry Schein (HSIC) posts lower-than-expected earnings and revenues in the fourth quarter of 2023.

Henry Schein (HSIC) Lags Q4 Earnings and Revenue Estimates

Henry Schein (HSIC) delivered earnings and revenue surprises of -5.71% and 1.83%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Seeking Clues to Henry Schein (HSIC) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics

Besides Wall Street's top -and-bottom-line estimates for Henry Schein (HSIC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.